Privia Health (PRVA) EBITDA (2020 - 2026)

Privia Health has reported EBITDA for 7 years, with the latest figure at $7.6 million in Q1 2026.

• For the quarter ending Q1 2026, EBITDA rose 38.96% year-over-year to $7.6 million; the trailing twelve-month figure through Mar 2026 stood at $37.1 million (up 65.5% YoY), and the FY2025 full-year result was $35.0 million, up 93.38% from the prior year.
• EBITDA for Q1 2026 stood at $7.6 million, down from $11.4 million in the prior quarter.
• The five-year high for EBITDA was $14.6 million in Q3 2025, with the low at -$11.2 million in Q1 2022.
• Average EBITDA over 5 years is $3.8 million, with a median of $5.4 million recorded in 2025.
• Year-over-year, EBITDA plunged 237.22% in 2022 and soared 387.56% in 2025.
• Tracing PRVA's EBITDA over 5 years: stood at $2.5 million in 2022, then tumbled by 32.49% to $1.7 million in 2023, then soared by 219.11% to $5.5 million in 2024, then soared by 108.86% to $11.4 million in 2025, then plunged by 33.83% to $7.6 million in 2026.
• The last three EBITDA figures came in at $7.6 million (Q1 2026), $11.4 million (Q4 2025), and $14.6 million (Q3 2025), per Business Quant data.

Peer Comparison